Cargando…

Survival Benefit of Adjuvant Chemotherapy After Pancreatoduodenectomy for Ampullary Adenocarcinoma: a Propensity-Matched National Cancer Database (NCDB) Analysis

BACKGROUND: The benefit of adjuvant chemotherapy (AC) after pancreatoduodenectomy (PD) for ampullary adenocarcinoma is uncertain. We aimed to evaluate the association of AC with survival in patients with resected ampullary adenocarcinoma. METHODS: Using the National Cancer Database (NCDB) data from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamarajah, Sivesh K., Bednar, Filip, Cho, Clifford S., Nathan, Hari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275534/ https://www.ncbi.nlm.nih.gov/pubmed/33230687 http://dx.doi.org/10.1007/s11605-020-04879-x

Ejemplares similares

Pancreatoduodenectomy for bile duct and ampullary cancer
por: Yamaguchi, Koji
Publicado: (2011)

Intraductal dissemination of ampullary carcinoma after pancreatoduodenectomy
por: Mohri, Koichi, et al.
Publicado: (2019)

The Evolution of Neo-Adjuvant Therapy in the Treatment of Oesophageal and Gastro-Oesophageal Junction Adenocarcinomas
por: Dermanis, Alexander A., et al.
Publicado: (2023)

Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population-Based Cohort Study
por: Kamarajah, Sivesh K., et al.
Publicado: (2021)

Effects of Serum Lipids on the Long-Term Prognosis of Ampullary Adenocarcinoma Patients after Curative Pancreatoduodenectomy
por: Li, Zheng, et al.
Publicado: (2022)

Advantage of endoscopic papillectomy for ampullary tumors as an alternative treatment for pancreatoduodenectomy
por: Abe, Shohei, et al.
Publicado: (2022)

Impact of Diabetes on Short-Term and Long-Term Outcomes of Ampullary Adenocarcinoma Patients after Curative Pancreatoduodenectomy
por: Zhang, Xiaojie, et al.
Publicado: (2022)

Comparison of Minimally Invasive versus Open Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Propensity Score Matching Analysis
por: Kwon, Jaewoo, et al.
Publicado: (2020)

Emergency Pancreatoduodenectomy for Ampullary Cancer Post-Iatrogenic Duodenal Perforation: No Option but to Strike
por: Varshney, Vaibhav K, et al.
Publicado: (2020)

Oncological outcomes of robotic-assisted versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score-matched analysis
por: Weng, Yuanchi, et al.
Publicado: (2020)

Pancreatoduodenectomy with portal vein resection favors the survival time of patients with pancreatic ductal adenocarcinoma: A propensity score matching analysis
por: Xie, Zhi-Bo, et al.
Publicado: (2019)

Single Center, Propensity Score Matching Analysis of Different Reconstruction Techniques following Pancreatoduodenectomy
por: Bellotti, Ruben, et al.
Publicado: (2023)

Analysis of Post-operative Adjuvant Chemotherapy Versus Adjuvant Chemoradiation Therapy Outcomes in Non-metastatic Cholangiocarcinoma: an NCDB Review
por: Rodriguez, Robin R., et al.
Publicado: (2021)

Ampullary adenocarcinoma – differentiation matters
por: Schirmacher, Peter, et al.
Publicado: (2008)

Survival Benefit of Resection Surgery for Pancreatic Ductal Adenocarcinoma with Liver Metastases: A Propensity Score-Matched SEER Database Analysis
por: Pausch, Thomas M., et al.
Publicado: (2021)

ASO Author Reflections: Challenges in the Management of Gastroesophageal Junctional Adenocarcinoma
por: Kamarajah, Sivesh K., et al.
Publicado: (2021)

Minimally-invasive versus open pancreatoduodenectomies with vascular resection: A 1:1 propensity-matched comparison study
por: Yang, Edwin, et al.
Publicado: (2022)

Prognostic implications of the extent of downstaging after neoadjuvant therapy for oesophageal adenocarcinoma and oesophageal squamous cell carcinoma
por: Kamarajah, Sivesh K, et al.
Publicado: (2023)

Comparison of clinical outcomes according to the history of previous gastrectomy in patients undergoing pancreatoduodenectomy: a propensity score matching analysis
por: Kim, Jae Ri, et al.
Publicado: (2020)

Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital - Mayo Clinic collaborative study
por: Narang, Amol K, et al.
Publicado: (2011)

Colorectal cancer in the 45-to-50 age group in the United States: a National Cancer Database (NCDB) analysis
por: Reif de Paula, Thais, et al.
Publicado: (2021)

Adjuvant chemotherapy versus chemoradiation in high‐risk pancreatic adenocarcinoma: A propensity score‐matched analysis
por: Raoof, Mustafa, et al.
Publicado: (2019)

Mucins Differently Expressed in Various Ampullary Adenocarcinomas
por: Wang, Tao, et al.
Publicado: (2011)

Mediastinal lymphadenopathy in ampullary adenocarcinoma: not always metastatic
por: Rao, Chalapathi A.S., et al.
Publicado: (2012)

Ampullary Adenocarcinoma Causing Small Intestinal Obstruction
por: Abudalou, Mohammad, et al.
Publicado: (2020)

Pancreatoduodenectomy following neoadjuvant chemotherapy in duodenal adenocarcinoma
por: Seo, Dongjin, et al.
Publicado: (2023)

Prognostic and Predictive Value of Circulating and Disseminated Tumor Cells in Breast Cancer: A National Cancer Database (NCDB) Analysis
por: Bilani, Nadeem, et al.
Publicado: (2020)

Outcomes of stage IV melanoma in the era of immunotherapy: a National Cancer Database (NCDB) analysis from 2014 to 2016
por: Sussman, Tamara A, et al.
Publicado: (2022)

Chondrosarcoma patient characteristics, management, and outcomes based on over 5,000 cases from the National Cancer Database (NCDB)
por: Ottesen, Taylor D., et al.
Publicado: (2022)

ASO Author Reflections: Assessing the Impact of Neoadjuvant Therapy: A Real View Perspective
por: Kamarajah, Sivesh K., et al.
Publicado: (2020)

ASO Author Reflections: Anastomotic Leaks After Esophagectomy—No Impact on Long-Term Survival
por: Kamarajah, Sivesh K., et al.
Publicado: (2020)

ASO Author Reflections: Smoking Status Impact on Perioperative Morbidity and Long-Term Survival of Patients Undergoing Esophagectomy for Cancer
por: Kamarajah, Sivesh K., et al.
Publicado: (2021)

The Clinical Benefit of Adjuvant Therapy in Long-Term Survival of Early-Stage Ampullary Carcinoma: A Single Institutional Experience
por: Manne, Ashish, et al.
Publicado: (2020)

Adjuvant chemotherapy can benefit the survival of stage I lung adenocarcinoma patients with tumour spread through air spaces after resection: Propensity-score matched analysis
por: Xie, Shaonan, et al.
Publicado: (2022)

Rare Orbital Metastasis Originating from Ampullary Adenocarcinoma
por: Tsai, Yung-En, et al.
Publicado: (2021)

Peritoneal Loose Body in a Patient With Ampullary Adenocarcinoma
por: Pradeep, A.V., et al.
Publicado: (2021)

Odds of Stage IV Bone Cancer Diagnosis Based on Socioeconomic and Geographical Factors: A National Cancer Database (NCDB) Review
por: McMahon, Kevin M, et al.
Publicado: (2023)

Regional pancreatoduodenectomy versus standard pancreatoduodenectomy with portal vein resection for pancreatic ductal adenocarcinoma with portal vein invasion
por: Oba, A., et al.
Publicado: (2020)

Vater’s ampullary carcinoma increases the risk of clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy: A retrospective and propensity score-matched analysis
por: Yang, Yifei, et al.
Publicado: (2022)

Pancreatoduodenectomy without Vascular Resection in Patients with Primary Resectable Adenocarcinoma and Unilateral Venous Contact: A Matched Case Study
por: Morelli, Luca, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qalsqgq1joock0ivmgucgiau1n